Zealand Pharma A/S (ZLDPF)
38.95
-10.80
(-21.71%)
USD |
OTCM |
Jun 08, 16:00
Zealand Pharma SG&A Expense (Quarterly) : 16.29M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Genmab A/S | 166.61M |
| Ascendis Pharma A/S | 169.91M |
| Bavarian Nordic A/S | 47.93M |
| Evaxion AS | 1.527M |
| Novo Nordisk A/S | 2.070B |